CENCORA: FORMERLY AMERISOURCEBERGEN
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com
CENCORA THINKLIVE CELL AND GENE THERAPY VIRTUAL SUMMIT 2025
The Cencora ThinkLive Cell and Gene Therapy Virtual Summit 2025, held May 20 – 21, 2025, gathered industry leaders, healthcare experts, and innovators to explore the latest advancements in cell and gene therapy. With over 30 speakers and 11 informative sessions across six tracks, the summit provided a platform for discussing critical topics such as the evolving regulatory landscape, patient support programs, and strategic partnerships aimed at enhancing patient access to therapies. Esteemed speakers shared their insights on the challenges faced by health systems in administering these innovative treatments and the importance of aligning patient services with real patient needs.
CELL & GENE THERAPIES
Your therapy can make all the difference. Together, we'll unlock its potential.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-1200230502 documents, process, team, office]( "Creating A Compliant And Scalable CGT Logistics Launch Plan")
As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.
-
![Gene therapy iStock-1300754583]( "ThinkLive Cell and Gene Therapy Summit 2025 Summary")
From patient support to intricate logistics, ThinkLive CGT Summit 2025 leaders tackled the essential commercial strategies needed to deliver these innovative therapies to patients globally.
-
![GettyImages-1443965506 doctor clinical trial data monitoring]( "Navigating Regulatory Complexity In CGT Development, Commercialization")
To successfully commercialize cell and gene therapies, understanding evolving US regulatory mandates is key. Consider these strategies to avoid delays and ensure compliance.
-
![GettyImages-953088038 patient network]( "Addressing Market Access Challenges As CGTs Expand To Larger Patient Populations")
Navigating market access for advanced therapies requires new strategies. Explore ways to boost payer understanding, innovate pricing, and adapt treatment settings as these therapies expand.
-
![GettyImages-1838438985 opthamology]( "The Future Promise Of Advanced Therapies In Ophthalmology")
Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Navigating Patient Access Challenges When Bringing Your CGT Product To Market")
Bringing cell and gene therapies to market requires more than scientific breakthroughs; manufacturers must navigate complex patient access challenges to ensure these innovations reach those in need.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
VIDEOS AND WEBINARS
-
![Cencora - Orchestration]( "Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management")
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order ManagementStreamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![Navigating Special Regulatory Pathways For Advanced Therapy Development Success]( "Navigating Special Regulatory Pathways For Advanced Therapy Development Success")
Navigating Special Regulatory Pathways For Advanced Therapy Development SuccessDon't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
-
![The Power Of Integrated Distribution Strategies]( "The Power Of Integrated Distribution Strategies")
The Power Of Integrated Distribution StrategiesDiscover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.
BLOGS
-
![GettyImages-1480558197 Business Corporate Team Meeting]( "Enabling Market Access As CGTs Reach More Patients")
Enabling Market Access As CGTs Reach More PatientsBringing potentially curative cell and gene therapies to more patients requires a focused approach to market access. Discover essential insights into payer dynamics, pricing innovations, and treatment evolution.
-
![GettyImages-1495393006 opthalmology, eye care]( "A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here")
A Bright Future For Eye Care: The Advanced Therapy Revolution Is HereGroundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.
-
![Doctor talking to patient-GettyImages-1330555438]( "Navigating Patient Access Challenges In Commercializing Your CGT Product")
Navigating Patient Access Challenges In Commercializing Your CGT ProductLearn how to effectively break down barriers to patient access in cell and gene therapy by enhancing provider education, streamlining coordination, and expanding patient support.
-
![GettyImages-1938542776 doctor patient]( "Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy")
Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel StrategyRare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.
-
![GettyImages-547131922 research, regulatory, lab]( "Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ")
Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQThe FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
